Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes.

Autor: Leong DP; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Fradet V; Centre de Recherche du CHU de Québec, Université Laval, Quebec City, Quebec, Canada., Niazi T; Jewish General Hospital, Montreal, Quebec, Canada., Selvanayagam JB; Southern Area Local Health Network and Flinders University of South Australia, Adelaide, Australia., Sabbagh R; Faculty of Medicine, University of Sherbrooke, Montreal, Quebec, Canada., Higano CS; University of British Columbia and Madrona Oncology, Seattle, Washington, USA., Agapay S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada., Rangarajan S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada., Mian R; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada., Nakashima CAK; Faculdades Pequeno Príncipe, Sociedade Hospitalar Angelina Caron, Araçatuba, Brazil., Mousavi N; McGill University Health Centre, Montreal, Quebec, Canada., Brown I; Division of Urology, Niagara Health System, St. Catharines, Ontario, Canada., Valle FH; Division of Cardiology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Lavallée LT; Division of Urology, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Shayegan B; Division of Urology, Department of Surgery, St. Joseph's Healthcare Hamilton and McMaster University, Hamilton, Ontario, Canada., Ng KKH; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Gopaul DD; Grand River Regional Cancer Centre, Kitchener, Ontario, Canada., Cavalli GD; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Saavedra S; Faculty of Medicine, University of La Frontera, Temuco, Chile., Lopez-Lopez JP; Masira Research Institute, Universidad de Santander, Bucaramanga, Colombia., Freitas de Souza C; Núcleo de Pesquisa Clínica - Rede São Camilo and Instituto Brasileiro de Controle do Cancer, São Paolo, Brazil., Duceppe E; Department of Medicine, Centre Hospitalier de l'Université de Montreal, Montreal, Quebec, Canada., Avezum Oliveira LF; Centro de Pesquisa Clínica do HC-UFTM, Uberaba, Brazil., Guha A; Augusta University, Augusta, Georgia, USA., Gomez-Mesa JE; Department of Health Sciences and Fundacíon Valle del Lili, Universidad Icesi, Cali, Colombia., Eduardo Silva Móz L; Clinical Oncology Department, Santa Casa de São Paolo Hospital, São Paolo, Brazil., Violette PD; Woodstock Hospital, McMaster University, Woodstock, Ontario, Canada., Avezum Á; International Research Center, Hospital Alemão Oswaldo Cruz, São Paolo, Brazil., Oliveira GBF; International Research Center, Hospital Alemão Oswaldo Cruz, São Paolo, Brazil., Kann AG; International Research Center, Hospital Alemão Oswaldo Cruz, São Paolo, Brazil., Walter E; Centro de Oncologia do Hospital de Clínicas Ijuí, Ijuí, Brazil., Dusilek COL; Hospital Rocio, Curitiba, Brazil., Villareal Trujillo N; FOSCAL Internacional Clinic, Floridablanca, Colombia., Beato P; Centro de Pesquisas Clínicas da Fundação Doutor Amaral Carvalho, São Paolo, Brazil., Hajjar LA; Faculdade de Medicina da Universidade de São Paolo, São Paolo, Brazil., Luke PPW; Department of Surgery, London Health Science Centre, London, Ontario, Canada., Schlabendorff E; Mãe de Deus Hospital, Porto Alegre, Brazil., Sarid D; Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel., Pinthus J; Department of Surgery, McMaster University, Hamilton, Ontario, Canada.

Publikováno v: JACC. CardioOncology [JACC CardioOncol] 2024 Sep 03; Vol. 6 (5), pp. 761-771. Date of Electronic Publication: 2024 Sep 03 (Print Publication: 2024).

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Autor: Videtic GM; Cleveland Clinic Foundation, Cleveland, Ohio. Electronic address: videtig@ccf.org., Paulus R; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania., Singh AK; Roswell Park Cancer Institute, Buffalo, New York., Chang JY; MD Anderson Cancer Center, Houston, Texas., Parker W; McGill University, Montreal, Québec, Canada., Olivier KR; Mayo Clinic, Rochester, Minnesota., Timmerman RD; UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas., Komaki RR; MD Anderson Cancer Center, Houston, Texas., Urbanic JJ; UC San Diego Moores Cancer Center Accruals-Arizona Oncology Services Foundation, San Diego, California., Stephans KL; Cleveland Clinic Foundation, Cleveland, Ohio., Yom SS; UCSF Medical Center, San Francisco, California., Robinson CG; Washington University, St. Louis, Missouri., Belani CP; The Pennsylvania State University Accruals-Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Iyengar P; UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas., Ajlouni MI; Henry Ford Hospital, Detroit, Michigan., Gopaul DD; Grand River Regional Cancer Centre Accruals-London Regional Cancer Centre., Gomez Suescun JB; Roswell Park Cancer Institute, Buffalo, New York., McGarry RC; University of Kentucky/Markey Cancer Center Accruals-University of Maryland Medical Systems., Choy H; UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas., Bradley JD; Washington University, St. Louis, Missouri.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Apr 01; Vol. 103 (5), pp. 1077-1084. Date of Electronic Publication: 2018 Dec 01.

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

Autor: Lukka HR; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada. Electronic address: lukkahim@hhsc.ca., Pugh SL; NRGOncologyStatistics and Data Management Center, Philadelphia, Pennsylvania., Bruner DW; Emory University, Winship Cancer Institute, Atlanta, Georgia., Bahary JP; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Lawton CAF; Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin., Efstathiou JA; Massachusetts General Hospital, Boston, Massachusetts., Kudchadker RJ; MD Anderson Cancer Center, Houston, Texas., Ponsky LE; Case Western Reserve University, Cleveland, Ohio., Seaward SA; Kaiser Permanente Northern California, Santa Clara, California., Dayes IS; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Gopaul DD; Grand River Hospital, Kitchener, Ontario, Canada., Michalski JM; Washington University, St Louis, Missouri., Delouya G; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Kaplan ID; Dana-Farber Cancer Institute, Boston, Massachusetts., Horwitz EM; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Roach M 3rd; University of California-San Francisco Medical Center, San Francisco, California., Pinover WH; Abington Memorial Hospital, Abington, Pennsylvania., Beyer DC; Arizona Oncology Services Foundation, Tucson, Arizona., Amanie JO; Cross Cancer Institute, Edmonton, Alberta, Canada., Sandler HM; Cedars-Sinai Medical Center, Los Angeles, California., Kachnic LA; Vanderbilt University Medical Center, Nashville, Tennessee.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 Oct 01; Vol. 102 (2), pp. 287-295. Date of Electronic Publication: 2018 Jun 18.